Table 2 Multivariate logistic regression analysis to determine risk factors affecting CAC.

From: Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity

Variables

All participants

Obese participants

Non-obese participants

OR (95% CI)

P-value

OR (95% CI)

P-value

OR (95% CI)

P-value

Age

1.11 (1.10–1.12)

<0.001

1.12 (1.10–1.13)

<0.001

1.11 (1.10–1.12)

<0.001

Male sex

3.24 (2.65–3.97)

<0.001

3.59 (2.67–4.83)

<0.001

2.88 (2.16–3.83)

<0.001

Hypertension

1.82 (1.57–2.11)

<0.001

1.65 (1.34–2.03)

<0.001

2.06 (1.66–2.56)

<0.001

Diabetes

1.82 (1.43–2.33)

<0.001

1.70 (1.19–2.44)

0.004

1.98 (1.42–2.77)

<0.001

Obesity

1.27 (1.08–1.49)

0.004

    

Abdominal obesity

1.12 (0.90–1.40)

0.298

1.26 (0.71–2.26)

0.428

1.19 (0.91–1.55)

0.216

NAFLD

1.23 (1.06–1.44)

0.007

1.20 (0.95–1.52)

0.122

1.25 (1.02–1.54)

0.034

eGFR

1.00 (0.99–1.01)

0.836

1.01 (1.00–1.02)

0.150

0.99 (0.99–1.00)

0.091

CRP

1.00 (0.99–1.02)

0.904

1.00 (0.98–1.01)

0.905

1.01 (0.99–1.04)

0.397

Current smoking

1.27 (1.07–1.51)

0.008

1.14 (0.88–1.48)

0.310

1.44 (1.13–1.84)

0.004

Alcohol status

1.06 (0.90–1.24)

0.517

1.18 (0.92–1.51)

0.192

0.95 (0.77–1.19)

0.678

AST

1.01 (1.00–1.02)

0.006

1.02 (1.00–1.03)

0.013

1.01 (1.00–1.02)

0.049

ALT

1.00 (0.99–1.00)

0.252

1.00 (1.00–1.00)

0.482

0.99 (0.98–1.00)

0.083

γ-GT

1.00 (1.00–1.00)

0.077

1.00 (1.00–1.00)

0.798

1.00 (1.00–1.01)

0.027

  1. CAC, coronary artery calcification; NAFLD, non-alcoholic fatty liver disease; eGFR, estimated glomerular filtration rate; CRP, C-reactive protein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GT, gamma-glutamyl transpeptidase; OR, odds ratio; CI, confidence interval.
Back to article page